CHICAGO, January 17, 2026 (Newswire.com) - Disclaimer: This article is for informational purposes only
Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR, et al
Researchers aren't exactly clear why the drug appears to work better in people with overweight or obesity (but not diabetes) compared to people with diabetes who also have overweight or obesity
The gut microbiota, as a critical microbial organ, has garnered extensive attention for its role in neuropsychiatric disorders such as SZ
Tirzepatide sold as Mounjaro for type 2 diabetes and Zepbound for weight management became the worlds best-selling drug in 2025 with combined global sales of $36.5 billion
Here's an honest look at the trade-offs